Regulatory Risk Classifier (UK)

Answer a few questions about how a peptide is presented, sold, or described. Get a low / moderate / high regulatory-sensitivity reading and an explanation of the patterns that drove it.

Is it an MHRA-approved medicine for the use described?

Is the compound (or a close analogue) a prescription-only medicine somewhere?

Are medicinal / treatment claims made about it?

Is it sold as 'research use only'?

Is it clearly intended for human use?

Is it advertised for body composition, injury, fertility, cognition, or disease?

Is there sourcing or affiliate content involved?

Not legal advice. Read more in our UK regulation hub and MHRA explainer.